Skip to main content
. 2021 May 11;60(Suppl 1):e32–e43. doi: 10.1055/s-0041-1728757

Table 5. Prediction performance for 3-month treatment outcomes. Parentheses denote standard deviations in cross validation.

Target Model Validation BS Testing BS
<6.5% RF 0.2294 (0.0256) 0.1634
GBT 0.1684 (0.0198) 0.1430
TPGE 0.1315 (0.0025) 0.1389
<7.0% RF 0.1949 (0.0237) 0.1939
GBT 0.1961 (0.0243) 0.1616
TPGE 0.1437 (0.0032) 0.1576
<7.5% RF 0.2741 (0.0569) 0.1682
GBT 0.1727 (0.0067) 0.1448
TPGE 0.1319 (0.0027) 0.1405
<8.0% RF 0.2197 (0.0828) 0.1307
GBT 0.1317 (0.0102) 0.1121
TPGE 0.1059 (0.0022) 0.1098
<8.5% RF 0.0944 (0.0040) 0.1030
GBT 0.0945 (0.0040) 0.0854
TPGE 0.0809 (0.0018) 0.0850
Average RF 0.2025 (0.0386) 0.1518
GBT 0.1527 (0.0130) 0.1294
TPGE 0.1188 (0.0025) 0.1264

Abbreviations: BS, Brier Score; GBT, Gradient Boosting Tree; RF, Random Forest; TPGE, Treatment Pathway Graph-based Estimation.